Common Myths About Clinical Trials: What Patients Should Know

Clinical trials play a critical role in advancing medicine, yet many patients hesitate to participate because of common misconceptions. These studies help researchers discover new ways to prevent, detect and treat disease while ensuring that treatments are safe and effective. Without clinical trials, many of the medications, procedures and therapies used in modern medicine would not exist.

Despite their importance, clinical trials are often misunderstood. Separating fact from fiction can help patients better understand how these studies work and the important role they play in improving health care.

    Myth #1: Clinical trials are only for people who have no other options.

    One of the most common misconceptions is that clinical trials are only offered to patients who have exhausted every other treatment. Clinical trials are available for many different stages of disease and sometimes even for prevention.

    Many studies evaluate new medications or treatments alongside existing therapies, giving patients access to potential advancements while still receiving standard care.

    “Clinical trials are not only for patients who have run out of treatment options,” Rambod A. Rouhbakhsh, MD, principal investigator with Hattiesburg Clinic Clinical Research, says. “They are designed to answer important medical questions and can be appropriate at many different points in a patient’s care.”

    Participation can sometimes provide access to promising therapies that are not yet widely available, while still allowing patients to continue the care recommended by their physician.

    Myth #2: Participants are treated like test subjects.

    Some people imagine clinical trials as risky experiments where participants are simply used for research. However, clinical trials follow strict ethical and safety guidelines designed to protect patients at every stage.

    Before a study ever begins, it must go through extensive review by regulatory agencies and independent review boards. These groups evaluate the design of the study and ensure it meets ethical and scientific standards.

    “Informed consent is a critical part of the clinical trial process,” Ronald L. Schwartz, MD, CPI, principal investigator with Hattiesburg Clinic Memory Center, explains. “Participants receive detailed information about the study, including potential risks and benefits, so they can make an informed decision before enrolling.”

    Participants are also closely monitored throughout the study. Research teams track outcomes, review safety data and maintain ongoing communication with participants to ensure their well-being.

    Myth #3: You might receive no treatment at all.

    Another common concern is the possibility of receiving a placebo instead of real treatment. While placebos are sometimes used in clinical research, they are not used in situations where doing so would deny a patient necessary care.

    In many studies, participants receive either the current standard treatment or a new therapy being evaluated. This approach allows researchers to compare results and determine whether the new treatment provides additional benefits.

    “Patient safety is always the top priority in clinical research,” John S. “Bo” Hrom, MD, FACP, with Hattiesburg Clinic Hematology/Oncology, says. “If an effective treatment already exists, patients will continue receiving appropriate care while researchers evaluate new options.”

    In many cases, clinical trial participants receive the same level of care they would normally receive, with the added benefit of contributing to medical research.

    Myth #4: Clinical trials are unsafe.

    Because clinical trials study new medications or technologies, some patients assume they are inherently unsafe. In fact, these studies are conducted under strict oversight and follow carefully designed protocols intended to protect participants.

    Before reaching the stage where patients are enrolled, new treatments often go through years of laboratory research and early testing. By the time they enter clinical trials, researchers already have important data about safety and potential effectiveness.

    “Clinical trials are conducted in phases, each designed to answer specific questions about safety and effectiveness,” Rouhbakhsh says. “This process helps ensure that new treatments are evaluated carefully and responsibly.”

    Participants are also monitored closely throughout the study, with regular visits, evaluations and opportunities to report any concerns.

    Myth #5: Participating in a clinical trial is complicated.

    Some patients worry that joining a clinical trial will require frequent travel, complicated procedures or major disruptions to their routine care. While every study is different, many clinical trials are designed to work alongside a patient’s existing treatment plan.

    Research teams guide participants through the process, explaining the details of the study and answering questions before enrollment begins.

    “Our goal is to make participation as clear and manageable as possible,” Schwartz says. “Patients always have the opportunity to review the study carefully and decide whether it is the right fit for them.”

    Participants also have the right to withdraw from a clinical trial at any time if they choose.

    The Impact of Clinical Trials

    Clinical trials have led to some of the most important medical breakthroughs in modern history. Treatments for cancer, heart disease, Alzheimer’s disease and many other conditions have advanced because patients chose to participate in research.

    These studies not only help future patients but can also benefit participants by providing access to emerging therapies and additional medical oversight.

    “Research is essential to improving patient outcomes,” Hrom says. “Clinical trials allow physicians to evaluate new approaches and continue advancing the care we provide.”

    For many patients, participation can be a meaningful way to contribute to the future of medicine while receiving care from experienced research teams.

    Clinical Research at Hattiesburg Clinic

    The clinical research team at Hattiesburg Clinic participates in clinical studies that support the advancement of medical technology and treatment practices. Clinical study opportunities are frequent and have already contributed to breakthrough treatments used internationally.

    Through these studies, physicians and researchers explore new ways to prevent, detect and treat disease. Hattiesburg Clinic offers clinical research trialshematology and oncology clinical trials and Alzheimer’s clinical trials.

    Patients who participate in clinical trials at Hattiesburg Clinic work with experienced physicians and research professionals who are committed to advancing medical knowledge while maintaining a strong focus on patient safety and high-quality care.

    ###

    About Hattiesburg Clinic:

    Hattiesburg Clinic is Mississippi’s largest privately-owned, multispecialty clinic. Founded in 1963, Hattiesburg Clinic has expanded to include over 450 physicians and providers, along with 2,500 employees, serving patients across more than 17 counties in Mississippi. Hattiesburg Clinic is committed to being the health care provider of choice in the communities we serve.

    Sources:

    https://www.nih.gov/health-information/nih-clinical-research-trials-you

    https://clinicaltrials.gov